Buy, hold, sell: Brainchip, CAR Group, and Endeavour shares

Let's see what analysts think about these shares this week.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Looking for ASX shares to buy after recent market weakness?

Well, if you are, let's see what analysts are saying about the popular shares in this article, courtesy of The Bull.

Are they buys, holds, or sells? Let's find out:

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.

Image source: Getty Images

Brainchip Holdings Ltd (ASX: BRN)

The team at Peak Asset Management has named this struggling semiconductor company as a sell this week.

It highlights that the small cap is battling against AI giants like Nvidia (NASDAQ: NVDA) in an intensively competitive sector. It said:

BrainChip is a commercial producer of neuromorphic artificial intelligence (AI). The company operates across Australia, the US and Europe and had a market capitalisation of about $A349.17 million during trading on March 12. The broader AI hardware landscape is increasingly dominated by big players, such as Nvidia.

The AI sector is intensively competitive. The company substantially lifted revenue in full year 2025, but reported a loss from continuing operations after tax. The shares have fallen from 24.5 cents on October 9, 2025 to trade at 14 cents on March 12. Other stocks appeal more at this stage of the cycle.

CAR Group Limited (ASX: CAR)

Over at Baker Young, its analysts are positive on this auto listings company.

It highlights that its shares have fallen heavily recently amid AI disruption concerns. However, the broker believes this has created a buying opportunity and has named it as a buy this week. It said:

This online automotive marketplace operator posted stronger-than-expected first half results for 2026. It grew revenue by 13 per cent and reported EBITDA by 11 per cent. Recent sector-wide selling driven largely by concerns around potential artificial intelligence (AI) disruption has weighed on valuations. However, we believe CAR's trusted brands, established distribution network and strong dealer relationships position it well to integrate AI tools into its services rather than be disrupted by them.

Over time, AI could enhance listing quality, pricing transparency and advertising effectiveness across its platforms. Given the company's strong market position, attractive margins and long runway for digital automotive marketplace growth across several geographies, we view recent price weakness as an opportunity to accumulate a high quality technology-enabled marketplace at a more reasonable valuation.

Endeavour Group Ltd (ASX: EDV)

Finally, Baker Young has been looking at drinks giant Endeavour. It felt that the Dan Murphy's owner delivered a solid half-year result last month.

However, it isn't enough for a buy rating just yet. The broker has put a hold rating on its shares instead. It said:

The drinks and hotels operator delivered solid first half results for fiscal year 2026. Hotel sales increased by 4.4 per cent and total retail sales increased by 0.2 per cent. Hotel sales growth in the first seven weeks of the second half of fiscal year 2026 was up 4.5 per cent followed by 1.3 per cent for retail sales.

The company is investing heavily in price competition to support volumes, which will likely pressure margins in the near term. While it may be too early to call a full recovery, we believe risks are broadly balanced and we're comfortable maintaining our position ahead of the strategic update.

Motley Fool contributor James Mickleboro has positions in Endeavour Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Nvidia. The Motley Fool Australia has recommended CAR Group Ltd and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: Endeavour, Magellan, and Rio Tinto shares

The team at Morgans has been running the rule over these shares recently.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

Should you buy Coles, Light & Wonder, and TPG Telecom shares in April?

Let's see if the team at Morgans rates these shares as buys ahead of the new month.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: Northern Star, Telix, and Virgin Australia shares

Let’s see if they are bullish or bearish on these names.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »